Apogee Therapeutics (APGE)
NASDAQ:APGE
APGE Analyst Ratings
Strong Buy
12 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
APGE Stock 12 Month Forecast
Average Price Target
$120.64
▲(43.04% Upside)
| Highest Price Target$160.00 | Average Price Target$120.64 | Lowest Price Target$82.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
BTIG
$137
Buy
62.44%
Upside
Reiterated
04/02/26
Deutsche Bank
$118
Buy
39.91%
Upside
Reiterated
04/02/26
Guggenheim
$160
Buy
89.71%
Upside
Reiterated
03/30/26
Mizuho Securities
$105→$110
Buy
30.42%
Upside
Reiterated
03/30/26
Canaccord Genuity
$89→$130
Buy
54.14%
Upside
Assigned
03/24/26
Truist Financial
―
Hold
―
Reiterated
03/24/26
Citi
$95→$125
Buy
48.21%
Upside
Reiterated
03/24/26
Craig-Hallum
$116→$114
Buy
35.17%
Upside
Reiterated
03/24/26
UBS
$100
Buy
18.57%
Upside
Reiterated
03/24/26
Stifel Nicolaus
―
Buy
―
Reiterated
03/23/26
Wedbush
$95→$120
Buy
42.28%
Upside
Reiterated
03/23/26
Bank of America Securities
$99→$131
Buy
55.32%
Upside
Reiterated
03/23/26
TD Cowen
―
Buy
―
Reiterated
03/10/26
RBC Capital
$83→$82
Hold
-2.77%
Downside
Reiterated
03/02/26
Wolfe Research
―
Hold
―
Initiated
01/07/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
BTIG
$137
Buy
62.44%
Upside
Reiterated
04/02/26
Deutsche Bank
$118
Buy
39.91%
Upside
Reiterated
04/02/26
Guggenheim
$160
Buy
89.71%
Upside
Reiterated
03/30/26
Mizuho Securities
$105→$110
Buy
30.42%
Upside
Reiterated
03/30/26
Canaccord Genuity
$89→$130
Buy
54.14%
Upside
Assigned
03/24/26
Truist Financial
―
Hold
―
Reiterated
03/24/26
Citi
$95→$125
Buy
48.21%
Upside
Reiterated
03/24/26
Craig-Hallum
$116→$114
Buy
35.17%
Upside
Reiterated
03/24/26
UBS
$100
Buy
18.57%
Upside
Reiterated
03/24/26
Stifel Nicolaus
―
Buy
―
Reiterated
03/23/26
Wedbush
$95→$120
Buy
42.28%
Upside
Reiterated
03/23/26
Bank of America Securities
$99→$131
Buy
55.32%
Upside
Reiterated
03/23/26
TD Cowen
―
Buy
―
Reiterated
03/10/26
RBC Capital
$83→$82
Hold
-2.77%
Downside
Reiterated
03/02/26
Wolfe Research
―
Hold
―
Initiated
01/07/26
Best Analysts Covering Apogee Therapeutics
3 Months
xxx
Success Rate
6/9 ratings generated profit
Average Return
+17.96%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +17.96% per trade.
1 Year
Success Rate
8/9 ratings generated profit
Average Return
+52.90%
reiterated a buy rating 14 days ago
Copying Geoff Meacham's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +52.90% per trade.
2 Years
xxx
Success Rate
10/11 ratings generated profit
Average Return
+67.60%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +67.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
APGE Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
11
10
7
22
19
Buy
10
22
18
21
9
Hold
1
8
8
36
29
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
40
33
79
57
Each month's total comprises the sum of three months' worth of ratings.
APGE Financial Forecast
APGE Stock Forecast FAQ
What is APGE’s average 12-month price target, according to analysts?
Based on analyst ratings, Apogee Therapeutics’s 12-month average price target is 120.64.
What is APGE’s upside potential, based on the analysts’ average price target?
Apogee Therapeutics has 43.04% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is APGE a Buy, Sell or Hold?
Apogee Therapeutics has a consensus rating of Strong Buy which is based on 12 buy ratings, 3 hold ratings and 0 sell ratings.
What is Apogee Therapeutics’s price target?
The average price target for Apogee Therapeutics is 120.64. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $160.00 ,the lowest forecast is $82.00. The average price target represents 43.04% Increase from the current price of $84.34.
The highest analyst price target is $160.00 ,the lowest forecast is $82.00. The average price target represents 43.04% Increase from the current price of $84.34.
What do analysts say about Apogee Therapeutics?
Apogee Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of APGE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.